Only a few observational studies have investigated the relation of genetic variants in the BCL-2-gene family, particularly the BCL2 gene, with susceptibility to myeloid leukemia, squamous cell carcinoma of the head and neck, esophageal cancer and prostate cancer [20]–[23]. This evidence concerns the gene BCL2 and prostate cancer.